These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 30762659)

  • 1. Use of direct oral anticoagulants in very elderly patients: a case report of apixaban in an ultracentenary patient.
    Manno G; Novo G; Corrado E; Coppola G; Novo S
    J Cardiovasc Med (Hagerstown); 2019 Jun; 20(6):403-405. PubMed ID: 30762659
    [No Abstract]   [Full Text] [Related]  

  • 2. Predictors for a high apixaban level in elderly patients with atrial fibrillation prescribed reduced dose of apixaban.
    Suzuki S; Yamashita T; Akao M; Okumura K
    Eur J Clin Pharmacol; 2021 Nov; 77(11):1757-1758. PubMed ID: 34014337
    [No Abstract]   [Full Text] [Related]  

  • 3. Acquired Hemophilia A in an Elderly Patient on Apixaban Therapy.
    Skorochod R; Applbaum Y; Nesher G; Tvito A
    Isr Med Assoc J; 2021 Feb; 23(2):130-131. PubMed ID: 33595223
    [No Abstract]   [Full Text] [Related]  

  • 4. Apixaban in the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation in France: Rationale and design of the PAROS cross-sectional study.
    Picard F; Ducrocq G; Danchin N; Falissard B; Hanon O; Mahe I; Touzé E; Steg PG
    Arch Cardiovasc Dis; 2018 May; 111(5):349-356. PubMed ID: 29191525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of Apixaban-Treated Patients, Evaluation of the Dose Prescribed, and the Persistence of Treatment: A Cohort Study in Catalonia.
    Gomez-Lumbreras A; Cortes J; Giner-Soriano M; Quijada-Manuitt MA; Morros R
    J Cardiovasc Pharmacol Ther; 2018 Nov; 23(6):494-501. PubMed ID: 29792125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apixaban, Rivaroxaban, and Dabigatran in Patients Undergoing Atrial Fibrillation Ablation.
    Rillig A; Lin T; Plesman J; Heeger CH; Lemes C; Metzner A; Mathew S; Wissner E; Wohlmuth P; Ouyang F; Kuck KH; Tilz RR
    J Cardiovasc Electrophysiol; 2016 Feb; 27(2):147-53. PubMed ID: 26464027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Anticoagulants for Postoperative Atrial Fibrillation After Coronary Artery Bypass Grafting: A Pilot Study.
    Chapin TW; Leedahl DD; Brown AB; Pasek AM; Sand MG; Loy ML; Dyke CM
    J Cardiovasc Pharmacol Ther; 2020 Nov; 25(6):523-530. PubMed ID: 32476465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Critical appraisal of the AUGUSTUS trial.
    Gremmel T; Sulzgruber P; Niessner A
    Eur Heart J Cardiovasc Pharmacother; 2019 Oct; 5(4):187-188. PubMed ID: 31265054
    [No Abstract]   [Full Text] [Related]  

  • 9. Rationale and design of AXAFA-AFNET 5: an investigator-initiated, randomized, open, blinded outcome assessment, multi-centre trial to comparing continuous apixaban to vitamin K antagonists in patients undergoing atrial fibrillation catheter ablation.
    Di Biase L; Callans D; Hæusler KG; Hindricks G; Al-Khalidi H; Mont L; Cosedis Nielsen J; Piccini JP; Schotten U; Kirchhof P
    Europace; 2017 Jan; 19(1):132-138. PubMed ID: 28130378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A rare side effect seen due to the use of apixaban: Palmoplantar psoriasiform drug eruption.
    Veliyev V; Özmen İ; Yaşar S; Gürsoy E; Köklü M; Çelik M
    Anatol J Cardiol; 2016 Mar; 16(3):213-5. PubMed ID: 27067558
    [No Abstract]   [Full Text] [Related]  

  • 11. Persistence on apixaban in atrial fibrillation patients: a retrospective multicentre study.
    Verdecchia P; D'Onofrio A; Russo V; Fedele F; Adamo F; Benedetti G; Ferrante F; Lodigiani C; Paciullo F; Aita A; Bartolini C; Molini MG; Di Lenarda A; Mazzone C; Scotti L; Lanati EP; Iorio A
    J Cardiovasc Med (Hagerstown); 2019 Feb; 20(2):66-73. PubMed ID: 30540644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adherence and outcomes to direct oral anticoagulants among patients with atrial fibrillation: findings from the veterans health administration.
    Borne RT; O'Donnell C; Turakhia MP; Varosy PD; Jackevicius CA; Marzec LN; Masoudi FA; Hess PL; Maddox TM; Ho PM
    BMC Cardiovasc Disord; 2017 Sep; 17(1):236. PubMed ID: 28865440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative safety and effectiveness of dabigatran vs. rivaroxaban and apixaban in patients with non-valvular atrial fibrillation: a retrospective study from a large healthcare system.
    Villines TC; Ahmad A; Petrini M; Tang W; Evans A; Rush T; Thompson D; Oh K; Schwartzman E
    Eur Heart J Cardiovasc Pharmacother; 2019 Apr; 5(2):80-90. PubMed ID: 30500885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Which oral anticoagulant for atrial fibrillation.
    Med Lett Drugs Ther; 2016 Apr; 58(1492):45-6. PubMed ID: 27049507
    [No Abstract]   [Full Text] [Related]  

  • 15. Novel oral anticoagulant and kidney injury: apixaban-related acute interstitial nephritis.
    Abdulhadi B; Mulki R; Goyal A; Rangaswami J
    BMJ Case Rep; 2017 Aug; 2017():. PubMed ID: 28847995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Initial apixaban dosing in patients with atrial fibrillation.
    Buchholz A; Ueberham L; Gorczynska K; Dinov B; Hilbert S; Dagres N; Husser D; Hindricks G; Bollmann A
    Clin Cardiol; 2018 May; 41(5):671-676. PubMed ID: 29542830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Major bleeding with apixaban in atrial fibrillation: patient characteristics, management, and outcomes.
    Eisho S; Salem NM; Hoffman JL; Koerber JM; Smythe MA
    Hosp Pract (1995); 2018 Oct; 46(4):165-169. PubMed ID: 30058431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation and Thrombocytopenia.
    Janion-Sadowska A; Papuga-Szela E; Łukaszuk R; Chrapek M; Undas A
    J Cardiovasc Pharmacol; 2018 Sep; 72(3):153-160. PubMed ID: 29985282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness and Safety of Dabigatran, Rivaroxaban, and Apixaban Versus Warfarin in Nonvalvular Atrial Fibrillation.
    Yao X; Abraham NS; Sangaralingham LR; Bellolio MF; McBane RD; Shah ND; Noseworthy PA
    J Am Heart Assoc; 2016 Jun; 5(6):. PubMed ID: 27412905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Managing Direct Oral Anticoagulants in Patients With Antiepileptic Medication.
    Dagan G; Perlman A; Hochberg-Klein S; Kalish Y; Muszkat M
    Can J Cardiol; 2018 Nov; 34(11):1534.e1-1534.e3. PubMed ID: 30404757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.